Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovastatin in Early Stage Parkinson's Disease
NCT03242499Phase 2Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- May 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing Lovastatin with Placebo (2 arms). Primary endpoint: Movement Disorder Society-Unified Parkinson's Disease Rating Scale Part III (Motor Subscale) at 48 weeks. Status: unknown.
02
Drugs
lovastatin
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03242499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03242499.